52 related articles for article (PubMed ID: 26464681)
1. Overexpression of prostate tumor overexpressed 1 correlates with tumor progression and predicts poor prognosis in breast cancer.
Lei F; Zhang L; Li X; Lin X; Wu S; Li F; Liu J
BMC Cancer; 2014 Jun; 14():457. PubMed ID: 24947166
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic, clinicopathological features and prognostic value of B7x expression in Chinese women with breast cancer: A meta-analysis.
Su H; Lin X; Huo J; Zhang F
Asian J Surg; 2023 Nov; 46(11):5210-5216. PubMed ID: 37481357
[No Abstract] [Full Text] [Related]
3. Gender Specific Mutation Incidence and Survival Associations in Clear Cell Renal Cell Carcinoma (CCRCC).
Ricketts CJ; Linehan WM
PLoS One; 2015; 10(10):e0140257. PubMed ID: 26484545
[TBL] [Abstract][Full Text] [Related]
4. New insights into tumor dormancy: Targeting DNA repair pathways.
Evans EB; Lin SY
World J Clin Oncol; 2015 Oct; 6(5):80-8. PubMed ID: 26468441
[TBL] [Abstract][Full Text] [Related]
5. A phase II trial of ixabepilone and cyclophosphamide as neoadjuvant therapy for patients with HER2-negative breast cancer: correlation of pathologic complete response with the 21-gene recurrence score.
Yardley DA; Peacock NW; Shastry M; Burris HA; Bechhold RG; Hendricks CB; Yoshizawa CN; Sing AP; Hainsworth JD
Breast Cancer Res Treat; 2015 Nov; 154(2):299-308. PubMed ID: 26507191
[TBL] [Abstract][Full Text] [Related]
6. PBRM1 Deficiency Confers Synthetic Lethality to DNA Repair Inhibitors in Cancer.
Chabanon RM; Morel D; Eychenne T; Colmet-Daage L; Bajrami I; Dorvault N; Garrido M; Meisenberg C; Lamb A; Ngo C; Hopkins SR; Roumeliotis TI; Jouny S; Hénon C; Kawai-Kawachi A; Astier C; Konde A; Del Nery E; Massard C; Pettitt SJ; Margueron R; Choudhary JS; Almouzni G; Soria JC; Deutsch E; Downs JA; Lord CJ; Postel-Vinay S
Cancer Res; 2021 Jun; 81(11):2888-2902. PubMed ID: 33888468
[TBL] [Abstract][Full Text] [Related]
7. Predictive Biomarkers for Immune Checkpoint Inhibitors in Metastatic Breast Cancer.
Sivapiragasam A; Ashok Kumar P; Sokol ES; Albacker LA; Killian JK; Ramkissoon SH; Huang RSP; Severson EA; Brown CA; Danziger N; McGregor K; Ross JS
Cancer Med; 2021 Jan; 10(1):53-61. PubMed ID: 33314633
[TBL] [Abstract][Full Text] [Related]
8. Research progress of SWI/SNF complex in breast cancer.
Li K; Wang B; Hu H
Epigenetics Chromatin; 2024 Feb; 17(1):4. PubMed ID: 38365747
[TBL] [Abstract][Full Text] [Related]
9. Pbrm1 intrinsically controls the development and effector differentiation of iNKT cells.
Wang X; Lei L; Su Y; Liu J; Yuan N; Gao Y; Yang X; Sun C; Ning B; Zhang B
J Cell Mol Med; 2022 Aug; 26(15):4268-4276. PubMed ID: 35770325
[TBL] [Abstract][Full Text] [Related]
10. Molecular Characterization, Via Next-Generation Sequencing, of Refractory or Resistant Invasive Breast Carcinoma.
Pose Lapausa P; Soria Comes T; Calabria I; Maestu Maiques I
Cureus; 2021 Nov; 13(11):e19528. PubMed ID: 34934548
[TBL] [Abstract][Full Text] [Related]
11. miR526b and miR655 Induce Oxidative Stress in Breast Cancer.
Shin B; Feser R; Nault B; Hunter S; Maiti S; Ugwuagbo KC; Majumder M
Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31430859
[TBL] [Abstract][Full Text] [Related]
12. New Insights into the Role of Polybromo-1 in Prostate Cancer.
Mota STS; Vecchi L; Zóia MAP; Oliveira FM; Alves DA; Dornelas BC; Bezerra SM; Andrade VP; Maia YCP; Neves AF; Goulart LR; Araújo TG
Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31212728
[TBL] [Abstract][Full Text] [Related]
13. PBRM1 Regulates Stress Response in Epithelial Cells.
Porter EG; Dhiman A; Chowdhury B; Carter BC; Lin H; Stewart JC; Kazemian M; Wendt MK; Dykhuizen EC
iScience; 2019 May; 15():196-210. PubMed ID: 31077944
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of Triple-Negative Breast Cancer Cell Aggressiveness by Cathepsin D Blockage: Role of Annexin A1.
Zóia MAP; Azevedo FVP; Vecchi L; Mota STS; Rodovalho VR; Cordeiro AO; Correia LIV; Silva ACA; Ávila VMR; Araújo TG; Goulart LR
Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30884823
[TBL] [Abstract][Full Text] [Related]
15. PBRM1 loss is a late event during the development of cholangiocarcinoma.
Luchini C; Robertson SA; Hong SM; Felsenstein M; Anders RA; Pea A; Nottegar A; Veronese N; He J; Weiss MJ; Capelli P; Scarpa A; Argani P; Kapur P; Wood LD
Histopathology; 2017 Sep; 71(3):375-382. PubMed ID: 28394406
[TBL] [Abstract][Full Text] [Related]
16. High-density array-CGH with targeted NGS unmask multiple noncontiguous minute deletions on chromosome 3p21 in mesothelioma.
Yoshikawa Y; Emi M; Hashimoto-Tamaoki T; Ohmuraya M; Sato A; Tsujimura T; Hasegawa S; Nakano T; Nasu M; Pastorino S; Szymiczek A; Bononi A; Tanji M; Pagano I; Gaudino G; Napolitano A; Goparaju C; Pass HI; Yang H; Carbone M
Proc Natl Acad Sci U S A; 2016 Nov; 113(47):13432-13437. PubMed ID: 27834213
[TBL] [Abstract][Full Text] [Related]
17. Low PBRM1 identifies tumor progression and poor prognosis in breast cancer.
Mo D; Li C; Liang J; Shi Q; Su N; Luo S; Zeng T; Li X
Int J Clin Exp Pathol; 2015; 8(8):9307-13. PubMed ID: 26464681
[TBL] [Abstract][Full Text] [Related]
18. Estrogen-responsive finger protein as a new potential biomarker for breast cancer.
Suzuki T; Urano T; Tsukui T; Horie-Inoue K; Moriya T; Ishida T; Muramatsu M; Ouchi Y; Sasano H; Inoue S
Clin Cancer Res; 2005 Sep; 11(17):6148-54. PubMed ID: 16144914
[TBL] [Abstract][Full Text] [Related]
19. Frequent low expression of chromatin remodeling gene ARID1A in breast cancer and its clinical significance.
Zhang X; Zhang Y; Yang Y; Niu M; Sun S; Ji H; Ma Y; Yao G; Jiang Y; Shan M; Zhang G; Pang D
Cancer Epidemiol; 2012 Jun; 36(3):288-93. PubMed ID: 21889920
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
